Cargando…

SARS-CoV-2, Early Entry Events

Viruses are obligate intracellular parasites, and host cell entry is the first step in the viral life cycle. The SARS-CoV-2 (COVID-19) entry process into susceptible host tissue cells is complex requiring (1) attachment of the virus via the conserved spike (S) protein receptor-binding motif (RBM) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chambers, James P., Yu, Jieh, Valdes, James J., Arulanandam, Bernard P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707962/ https://www.ncbi.nlm.nih.gov/pubmed/33299610 http://dx.doi.org/10.1155/2020/9238696

Ejemplares similares

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Role of host factors in SARS-CoV-2 entry
por: Evans, John P., et al.
Publicado: (2021)

Mechanisms of SARS-CoV-2 entry into cells
por: Jackson, Cody B., et al.
Publicado: (2021)

Entry, egress and vertical transmission of SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Roles of host proteases in the entry of SARS-CoV-2
por: Zabiegala, Alexandria, et al.
Publicado: (2023)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

SARS-CoV-2 cell entry and targeted antiviral development
por: Chen, Zinuo, et al.
Publicado: (2021)

Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
por: Barthe, Manon, et al.
Publicado: (2023)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

Alpha-1 Antitrypsin is Markedly Decreased Following Pulmonary F. tularensis Challenge
por: Chambers, James P., et al.
Publicado: (2011)

Influence of Fetuin-A on Chlamydia muridarum Pulmonary Infection
por: Mahjabeen, Faria, et al.
Publicado: (2022)

Cell entry mechanisms of SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
por: Xiang, Yusen, et al.
Publicado: (2021)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

Lipid rafts are involved in SARS-CoV entry into Vero E6 cells
por: Lu, Yanning, et al.
Publicado: (2008)

SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
por: Yu, Shi, et al.
Publicado: (2023)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
por: Al Adem, Kenana, et al.
Publicado: (2020)

Tumor markers as an entry for SARS‐CoV‐2 infection?
por: Xia, Pu, et al.
Publicado: (2020)

Contribution of Syndecans to the Cellular Entry of SARS-CoV-2
por: Hudák, Anett, et al.
Publicado: (2021)

Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors
por: Huang, Li, et al.
Publicado: (2022)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
por: Ahmad, Iqrar, et al.
Publicado: (2021)

Insights into Acinetobacter baumannii protective immunity
por: Jeffreys, Sean, et al.
Publicado: (2022)

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
por: Han, Dong P., et al.
Publicado: (2006)

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
por: Cheng, Fang-Ju, et al.
Publicado: (2023)

Essential oils block cellular entry of SARS-CoV-2 delta variant
por: Torres Neto, Luiz, et al.
Publicado: (2022)

Biochemical characterization of a recombinant acid phosphatase from Acinetobacter baumannii
por: Smiley-Moreno, Elizabeth, et al.
Publicado: (2021)

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
por: Murgolo, Nicholas, et al.
Publicado: (2021)

Identification of potent small molecule inhibitors of SARS-CoV-2 entry
por: Mediouni, Sonia, et al.
Publicado: (2022)

SARS-CoV-2 (COVID-19) superspreader events
por: Majra, Dasha, et al.
Publicado: (2021)

SARS-CoV-2 and Acute Cerebrovascular Events: An Overview
por: Ghasemi, Mehdi, et al.
Publicado: (2021)

Surface vimentin is critical for the cell entry of SARS-CoV
por: Yu, Yvonne Ting-Chun, et al.
Publicado: (2016)

Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium
por: Pinto, Andreia L., et al.
Publicado: (2022)

Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
por: Yuan, Zixuan, et al.
Publicado: (2020)

Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity
por: Sakaguchi, Wakako, et al.
Publicado: (2020)

Peptide and peptide-based inhibitors of SARS-CoV-2 entry
por: Schütz, Desiree, et al.
Publicado: (2020)

Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes
por: Yang, Jing, et al.
Publicado: (2021)

Coronavirus entry: how we arrived at SARS-CoV-2
por: Whittaker, Gary R, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fc9ur8o7l4n5mhn7hjfcru07c5